Alteration of Liver MMP-9/TIMP-1 and Plasma Type IV Collagen in the Development of Rat Insulin Resistance

  • Jun-feng Hou
  • Xiao-di Zhang
  • Xiao-guang Wang
  • Jing Wei
  • Kai Jiao
Conference paper
Part of the Lecture Notes in Electrical Engineering book series (LNEE, volume 269)


Insulin resistance (IR) is a risk factor of many diseases and present in various metabolic abnormalities including obesity, type 2 diabetes. Although several factors are believed to contribute to the initiating course of IR, fatty liver, hepatic injury or hepatic fibrosis is a prominent feature during IR development. Although a correlation between IR and hepatic injury has long been suspected, it remains unclear whether accumulation of fat in the liver is causally related to hepatic injury which in turn induces systemic IR. Using rat IR model with high-fat diet (HFD), the present study shows a time courses of expression of matrix metalloproteinases (MMP-9)/tissue inhibitors of metalloproteinases (TIMP-1) mRNA and protein in the liver as well as plasma type IV collagen (collagen-IV), and liver histology. The results showed that expression of MMP-9 mRNA and protein significantly increased in rat liver after 15 days in HFD group but decreased thereafter. In contrast, liver TIMP-1 and plasma collagen-IV levels gradually increased and reached to a peak at the end of 60 days in HFD group. Histological analysis revealed that livers from HFD group exhibited steatosis, and more collagen fibers were formed in the interspace among disse cavea and intruded into the tight junctions among hepatocytes detected by transmission electron microscope. The results indicated that the IR induced alteration of MMP-9 to TIMP-1 ratio may play a role in elevation of collagen-IV, which may participate in development of inchoate hepatic fibrosis in the later course of IR.


Insulin resistance Hepatic steatosis Hepatic fibrosis Type IV collagen MMP-9/TIMP-1 



The work was supported by grants from the Scientific Technological Research Planning of Shaanxi Province (2010K15-05-04). We also acknowledged the assistance from the Electronic Microscope Center of the Fourth Military Medical University.


  1. 1.
    Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefGoogle Scholar
  2. 2.
    DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194CrossRefGoogle Scholar
  3. 3.
    Marceau P, Biron S, Hould FS et al (1999) Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513–1517Google Scholar
  4. 4.
    Schwimmer JB, Deutsch R, Rauch JB et al (2003) Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143:500–505CrossRefGoogle Scholar
  5. 5.
    Marchesini G, Brizi M, Morselli-Labate AM et al (1999) Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107:450–455CrossRefGoogle Scholar
  6. 6.
    Marchesini G, Brizi M, Bianchi G et al (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850CrossRefGoogle Scholar
  7. 7.
    Chitturi S, Abeygunasekera S, Farrell GC et al (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35:373–379CrossRefGoogle Scholar
  8. 8.
    Ludwig J, McGill DB, Lindor KD (1997) Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 12:398–403CrossRefGoogle Scholar
  9. 9.
    Brunt EM, Janney CG, DiBisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474CrossRefGoogle Scholar
  10. 10.
    Powell EE, Cooksley WG, Hanson R et al (1990) The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years. Hepatology 11:74–80CrossRefGoogle Scholar
  11. 11.
    Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231CrossRefGoogle Scholar
  12. 12.
    Ground KE (1982) Liver pathology in aircrew. Aviat Space Environ Med 53:14–18Google Scholar
  13. 13.
    Hilden M, Christoffersen P, Juhl E et al (1977) Liver histology in a ‘normal’ population: examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 12:593–597CrossRefGoogle Scholar
  14. 14.
    Bellentani S, Saccoccio G, Masutti F et al (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112–117CrossRefGoogle Scholar
  15. 15.
    Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100CrossRefGoogle Scholar
  16. 16.
    García-Monzón C, Martín-Pérez E, Iacono OL et al (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33:716–724CrossRefGoogle Scholar
  17. 17.
    Hamaguchi M, Kojima T, Takeda N et al (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143:722–728CrossRefGoogle Scholar
  18. 18.
    Fan JG, Zhu J, Li XJ et al (2005) Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 20:1825–1832CrossRefGoogle Scholar
  19. 19.
    Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37:1202–1219CrossRefGoogle Scholar
  20. 20.
    Jiao K, Liu HL, Chen JK et al (2008) Roles of plasma interleukin-6 and tumor necrosis factor-α and FFA and TG in the development of insulin resistance induced by high-fat diet. Cytokine 42:161–169CrossRefGoogle Scholar
  21. 21.
    Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefGoogle Scholar
  22. 22.
    Matthews DR, Hosker JP, Rudenski AS et al (2002) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetes Care 25:1891–1892CrossRefGoogle Scholar
  23. 23.
    Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699CrossRefGoogle Scholar
  24. 24.
    Doggenweiler CF, Frenk S (1965) Staining properties of lanthanumon cell membranes. Proc Natl Acad Sci 53:425–430CrossRefGoogle Scholar
  25. 25.
    Chen CL, Huang SK, Lin JL et al (2008) Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation. J Mol Cell Cardiol 45:742–753CrossRefGoogle Scholar
  26. 26.
    Buettner R, Parhofer KG, Woenckhaus M et al (2006) Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 36:485–501CrossRefGoogle Scholar
  27. 27.
    Gupte P, Amarapurkar D, Agal S et al (2004) Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 19:854–858CrossRefGoogle Scholar
  28. 28.
    Assy N, Kaita K, Mymin D et al (2000) Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 45:1929–1934CrossRefGoogle Scholar
  29. 29.
    Donati G, Stagni B, Piscaglia F et al (2004) Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 53:1020–1023CrossRefGoogle Scholar
  30. 30.
    Biddinger SB, Kahn CR (2006) From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123–158CrossRefGoogle Scholar
  31. 31.
    Samuel VT, Liu ZX, Qu X et al (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345–32353CrossRefGoogle Scholar
  32. 32.
    Martinez Ortega, de Victoria E, Xu X, Koska J et al (2009) Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes 58:385–393Google Scholar
  33. 33.
    Haus JM, Kashyap SR, Kasumov T et al (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58:337–343CrossRefGoogle Scholar
  34. 34.
    Iredale JP (2001) Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 21:427–436CrossRefGoogle Scholar
  35. 35.
    Arthur MJ (1995) Collagenases and liver fibrosis. J Hepatol 22:43–48CrossRefGoogle Scholar
  36. 36.
    Benyon RC, Arthur MJ (2001) Extracellular of matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21:373–384CrossRefGoogle Scholar
  37. 37.
    Van Pham TD, Couchie N, Martin-Garcia Y et al (2008) Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat. Matrix Biol 27:674–681CrossRefGoogle Scholar
  38. 38.
    Nagase H (1996) Zinc metalloproteinases in health and disease. Taylor & Franics, London, pp 153–204Google Scholar
  39. 39.
    Han YP (2006) Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol 21(Suppl.3):S88–S91CrossRefGoogle Scholar
  40. 40.
    Han YP, Yan C, Zhou L et al (2007) A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three dimensional extracellular matrix. J Biol Chem 282:12928–12939CrossRefGoogle Scholar
  41. 41.
    Arthur MJ (2000) Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279:G245–G249Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Jun-feng Hou
    • 1
  • Xiao-di Zhang
    • 1
  • Xiao-guang Wang
    • 1
  • Jing Wei
    • 1
  • Kai Jiao
    • 2
  1. 1.Department of ToxicologyFourth Military Medical UniversityXi’anChina
  2. 2.Department of EndocrinologyTangdu Hospital, Fourth Military Medical UniversityXi’anChina

Personalised recommendations